+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Granisetron Market - Global Forecast 2026-2032- Product Image
Granisetron Market - Global Forecast 2026-2032- Product Image
New

Granisetron Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6017482
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The granisetron market is undergoing rapid transformation, demanding informed strategies from senior decision-makers as regulatory, clinical, and supply chain factors reshape access and adoption. Stakeholders must align procurement, manufacturing, and commercial approaches to remain ahead in this evolving therapeutic space.

Market Snapshot: Granisetron Market Growth and Dynamics

The granisetron market grew from USD 7.95 billion in 2025 to USD 8.50 billion in 2026. Continuing at a CAGR of 8.03%, it is projected to reach USD 13.65 billion by 2032. This sustained market expansion reflects both ongoing clinical reliance in oncology and perioperative care, and evolving developments in regulatory and supply chain environments.

Scope & Segmentation of the Granisetron Market

  • Dosage Forms: Injection (intravenous bolus and infusion), oral disintegrating tablet, standard oral tablet
  • Clinical Applications: Chemotherapy-induced nausea and vomiting (with acute and delayed phase distinctions), radiation-induced, and postoperative settings
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy options targeting tailored access and dispensing needs
  • End Users: Ambulatory surgical centers, clinics, and hospitals—each with distinct inventory and procurement frameworks
  • Product Types: Branded granisetron versus generics, shaping both price competition and commercial strategy
  • Regional Coverage: Americas, Europe Middle East & Africa, Asia-Pacific regions analysed for specific regulatory, market access, and commercial tactics

This segmentation enables precise insights across patient care settings, procurement patterns, and emerging commercialization opportunities.

Key Takeaways for Senior Stakeholders

  • Outpatient and ambulatory care models drive increased demand for convenient granisetron formulations, influencing manufacturer formulation pipelines and packaging choices.
  • Enhanced regulatory requirements for drug safety and traceability are raising the compliance bar, pressuring manufacturers to invest in serialization and quality management systems.
  • Procurement strategies are shifting towards longer-term and value-based contracts, as purchasers balance predictable supply with bundled service and price stability.
  • Supply chain resilience is now central, with purchasing teams emphasizing supplier diversification, local production partnerships, and dynamic inventory management to mitigate disruptions.
  • Differentiation increasingly depends on holistic offerings combining clinical evidence, patient support programs, and digital tools to support adherence and reduce care burdens.
  • Regional differences in regulatory requirements and purchasing behaviors necessitate flexible market entry tactics and customized evidence packages for optimal access.

Tariff Impact on the Granisetron Value Chain

United States tariff actions announced or anticipated in 2025 have introduced additional layers of complexity into pharmaceutical supply dynamics. Manufacturers are now recalibrating sourcing and inventory strategies to protect margins and preserve supply continuity amid fluctuating input costs and potential distribution delays. Health systems are responding through longer-term supplier agreements and diversification, evaluating local manufacturing options to buffer against tariff-driven volatility. Regulatory compliance in customs classification and documentation is a renewed focus area, elevating supply chain risk management as a strategic imperative. This environment has increased competitive differentiation between suppliers based on their supply agility and geographic footprint.

Granisetron Market Research Methodology & Data Sources

This report combines insights from primary interviews with clinical, procurement, and manufacturing leaders and rigorous secondary review of regulatory releases, trade policy documents, and public manufacturer disclosures. Scenario analysis, segmentation mapping, and options assessment ensure robust, actionable recommendations grounded in validated data.

Why This Report Matters for B2B Leaders

  • Supports strategic planning by mapping evolving risks and opportunities across the entire value chain
  • Provides granular segmentation to guide product launches, procurement protocols, and investment strategies
  • Equips commercial, operations, and supply chain teams to adapt sourcing and contracting models for ongoing resilience

Conclusion

The granisetron market demands proactive, multi-dimensional strategies that align supply reliability, evidence-driven positioning, and flexible operating models. Decision-makers who act now are best placed to ensure continued access, optimal performance, and competitive strength in an increasingly challenging environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Granisetron Market, by Dosage Form
8.1. Injection
8.1.1. Intravenous Bolus
8.1.2. Intravenous Infusion
8.2. Oral Disintegrating Tablet
8.3. Tablet
8.3.1. Standard
9. Granisetron Market, by Product Type
9.1. Branded
9.2. Generic
10. Granisetron Market, by Application
10.1. Chemotherapy-Induced Nausea And Vomiting
10.1.1. Acute Phase
10.1.2. Delayed Phase
10.2. Postoperative Nausea And Vomiting
10.3. Radiation-Induced Nausea And Vomiting
11. Granisetron Market, by Distribution Channel
11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.3. Retail Pharmacy
12. Granisetron Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Clinics
12.3. Hospitals
13. Granisetron Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Granisetron Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Granisetron Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Granisetron Market
17. China Granisetron Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Cipla Limited
18.6. Dr. Reddy’s Laboratories Limited
18.7. F. Hoffmann-La Roche Ltd
18.8. Fresenius Kabi AG
18.9. Glenmark Pharmaceuticals Limited
18.10. Hikma Pharmaceuticals PLC
18.11. Sandoz International GmbH
18.12. Sun Pharmaceutical Industries Limited
18.13. Teva Pharmaceutical Industries Limited
18.14. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL GRANISETRON MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GRANISETRON MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GRANISETRON MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GRANISETRON MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES GRANISETRON MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA GRANISETRON MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GRANISETRON MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GRANISETRON MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GRANISETRON MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GRANISETRON MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GRANISETRON MARKET SIZE, BY INTRAVENOUS BOLUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GRANISETRON MARKET SIZE, BY INTRAVENOUS BOLUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GRANISETRON MARKET SIZE, BY INTRAVENOUS BOLUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GRANISETRON MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GRANISETRON MARKET SIZE, BY INTRAVENOUS INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GRANISETRON MARKET SIZE, BY INTRAVENOUS INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GRANISETRON MARKET SIZE, BY ORAL DISINTEGRATING TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GRANISETRON MARKET SIZE, BY ORAL DISINTEGRATING TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GRANISETRON MARKET SIZE, BY ORAL DISINTEGRATING TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GRANISETRON MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GRANISETRON MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GRANISETRON MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GRANISETRON MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GRANISETRON MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GRANISETRON MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GRANISETRON MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GRANISETRON MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GRANISETRON MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GRANISETRON MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GRANISETRON MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GRANISETRON MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GRANISETRON MARKET SIZE, BY ACUTE PHASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GRANISETRON MARKET SIZE, BY ACUTE PHASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GRANISETRON MARKET SIZE, BY ACUTE PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GRANISETRON MARKET SIZE, BY DELAYED PHASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GRANISETRON MARKET SIZE, BY DELAYED PHASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GRANISETRON MARKET SIZE, BY DELAYED PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GRANISETRON MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GRANISETRON MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GRANISETRON MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GRANISETRON MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GRANISETRON MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GRANISETRON MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS GRANISETRON MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. EUROPE GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 106. EUROPE GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 108. EUROPE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. EUROPE GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 111. EUROPE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. EUROPE GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. AFRICA GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 124. AFRICA GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 125. AFRICA GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 126. AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 129. AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. AFRICA GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL GRANISETRON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 143. ASEAN GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 144. ASEAN GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 145. ASEAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. ASEAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. ASEAN GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 148. ASEAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. ASEAN GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GCC GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GCC GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 152. GCC GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 153. GCC GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 154. GCC GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. GCC GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. GCC GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 157. GCC GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. GCC GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 170. BRICS GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 171. BRICS GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 172. BRICS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. BRICS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. BRICS GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 175. BRICS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. BRICS GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. G7 GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. G7 GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 179. G7 GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 180. G7 GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 181. G7 GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. G7 GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. G7 GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 184. G7 GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. G7 GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. NATO GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. NATO GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 188. NATO GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 189. NATO GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 190. NATO GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. NATO GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. NATO GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 193. NATO GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. NATO GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES GRANISETRON MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. CHINA GRANISETRON MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. CHINA GRANISETRON MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 207. CHINA GRANISETRON MARKET SIZE, BY INJECTION, 2018-2032 (USD MILLION)
TABLE 208. CHINA GRANISETRON MARKET SIZE, BY TABLET, 2018-2032 (USD MILLION)
TABLE 209. CHINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. CHINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. CHINA GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, 2018-2032 (USD MILLION)
TABLE 212. CHINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. CHINA GRANISETRON MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

  • Cipla Limited
  • Dr. Reddy’s Laboratories Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.65 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Granisetron (CAS 109889-09-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Granisetron (CAS 109889-09-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Chemotherapy Induced Nausea & Vomiting Treatment Market - Global Forecast 2026-2032 - Product Image

Chemotherapy Induced Nausea & Vomiting Treatment Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025 - Product Image

Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Chemotherapy Induced Nausea Vomiting Market Report and Forecast 2025-2034 - Product Image

Chemotherapy Induced Nausea Vomiting Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report 2025 - Product Image

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

Granisetron is an antiemetic drug used in the treatment of nausea and vomiting caused by chemotherapy and radiotherapy in oncology patients. It is a serotonin 5-HT3 receptor antagonist, which works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. Granisetron is available in both oral and intravenous formulations, and is often used in combination with other antiemetics. It is generally well tolerated, with few side effects. Granisetron is used in the treatment of a variety of cancers, including breast, lung, colorectal, and ovarian cancer. It is also used to treat nausea and vomiting associated with other medical conditions, such as HIV/AIDS and postoperative nausea and vomiting. The Granisetron market is highly competitive, with a number of companies offering products in the space. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.